Rapid Micro Biosystems, Inc. (RPID) News
Filter RPID News Items
RPID News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest RPID News From Around the Web
Below are the latest news stories about RAPID MICRO BIOSYSTEMS INC that investors may wish to consider to help them evaluate RPID as an investment opportunity.
Rapid Micro Biosystems to Participate in Upcoming Investor ConferencesLOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY: Stifel 2023 Healthcare ConferenceQuestion-and-answer session with analyst on Wednesday, November 15th |
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call TranscriptRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript November 3, 2023 Rapid Micro Biosystems, Inc. beats earnings expectations. Reported EPS is $-0.31086, expectations were $-0.32. Operator: Thank you for holding, and welcome, everyone, to the Rapid Micro Biosystems’ Third Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any […] |
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue EstimatesRapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 3.12% and 11.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? |
Rapid Micro Biosystems Inc (RPID) Reports 30% Revenue Growth in Q3 2023Company Reaffirms Full Year 2023 Revenue Guidance at $22.0 Million |
Rapid Micro Biosystems Reports Third Quarter 2023 Financial ResultsReports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million, representing growth of approximately 30% compared to full year 2022 LOWELL, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufact |
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2023 financial results prior to the market open on Friday, November 3, 2023. In conjunction with the release, the Company’s management team will host a webcast conference call at |
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its participation as a platinum sponsor and exhibitor at the 2023 Parenteral Drug Association (“PDA”) Pharmaceutical Microbiology Conference from October 2 - 4 in Washington, D.C. This year |
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company ShowcaseLOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the virtual Gilmartin Group Emerging Growth Company Showcase. Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are scheduled to participate virtu |
Insider Buying: CFO Sean Wirtjes Acquires 10,000 Shares of Rapid Micro Biosystems IncOn September 6, 2023, Sean Wirtjes, the Chief Financial Officer of Rapid Micro Biosystems Inc (NASDAQ:RPID), made a significant purchase of 10,000 shares of the company's stock. |
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare ConferenceLOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference. Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are scheduled to participate in a 3 |